Tags

Type your tag names separated by a space and hit enter

Role of metformin in patients with polycystic ovary syndrome: the state of the art.
Minerva Ginecol. 2008 Feb; 60(1):77-82.MG

Abstract

Metformin, an insulin sensitizer widely used for the treatment of patients with type-2 diabetes mellitus (DM), was recently introduced in the clinical practice to treat women with polycystic ovary syndrome (PCOS). The aim of the current review was to evaluate the current role of metformin in the treatment of the PCOS-related disorders. The Authors analyze here the administration of metformin for treating the ovarian dysfunction due to PCOS, and show the evidences available in literature regarding its alternative uses.

Authors+Show Affiliations

Palomba S
Department of Gynecology and Obstetrics, Magna Graecia University of Catanzaro, Catanzaro, Italy. stefanopalomba@tin.it
Falbo A
No affiliation info available
Russo T
No affiliation info available
Orio F
No affiliation info available
Tollino A
No affiliation info available
Zullo F
No affiliation info available

MeSH

ClomipheneComorbidityDiabetes Mellitus, Type 2Drug Therapy, CombinationFemaleFertility Agents, FemaleHumansHypoglycemic AgentsMeta-Analysis as TopicMetforminOvaryOvulation InductionPolycystic Ovary SyndromePregnancyPregnancy OutcomeRandomized Controlled Trials as TopicRisk Factors

Pub Type(s)

Evaluation Study
Journal Article
Review

Language

eng

PubMed ID

18277354

Citation

Palomba, S, et al. "Role of Metformin in Patients With Polycystic Ovary Syndrome: the State of the Art." Minerva Ginecologica, vol. 60, no. 1, 2008, pp. 77-82.
Palomba S, Falbo A, Russo T, et al. Role of metformin in patients with polycystic ovary syndrome: the state of the art. Minerva Ginecol. 2008;60(1):77-82.
Palomba, S., Falbo, A., Russo, T., Orio, F., Tollino, A., & Zullo, F. (2008). Role of metformin in patients with polycystic ovary syndrome: the state of the art. Minerva Ginecologica, 60(1), 77-82.
Palomba S, et al. Role of Metformin in Patients With Polycystic Ovary Syndrome: the State of the Art. Minerva Ginecol. 2008;60(1):77-82. PubMed PMID: 18277354.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Role of metformin in patients with polycystic ovary syndrome: the state of the art. AU - Palomba,S, AU - Falbo,A, AU - Russo,T, AU - Orio,F, AU - Tollino,A, AU - Zullo,F, PY - 2008/2/16/pubmed PY - 2008/6/28/medline PY - 2008/2/16/entrez SP - 77 EP - 82 JF - Minerva ginecologica JO - Minerva Ginecol VL - 60 IS - 1 N2 - Metformin, an insulin sensitizer widely used for the treatment of patients with type-2 diabetes mellitus (DM), was recently introduced in the clinical practice to treat women with polycystic ovary syndrome (PCOS). The aim of the current review was to evaluate the current role of metformin in the treatment of the PCOS-related disorders. The Authors analyze here the administration of metformin for treating the ovarian dysfunction due to PCOS, and show the evidences available in literature regarding its alternative uses. SN - 0026-4784 UR - https://www.unboundmedicine.com/medline/citation/18277354/Role_of_metformin_in_patients_with_polycystic_ovary_syndrome:_the_state_of_the_art_ DB - PRIME DP - Unbound Medicine ER -